{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:40:40Z","timestamp":1790073640080,"version":"4.0.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":1614,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We sought to compare the effects of furosemide + hypertonic saline solution (HSS) treatment in patients with acute decompensated heart failure in comparison with furosemide alone and the response in a compensated state after an acute saline load with regard to serum levels of heart failure biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We enrolled 141 patients with acute decompensated heart failure with reduced ejection fraction admitted to our Internal Medicine ward from March 2017 to November 2019. A total of 73 patients were randomized to treatment with i.v. high-dose furosemide plus HSS, whereas 68 patients were randomized to i.v. high-dose furosemide alone. Patients treated with furosemide plus HSS compared with controls treated with furosemide alone showed a comparable degree of reduction in the serum levels of interleukin (IL)-6, soluble suppression of tumorigenicity 2 (sST2), and N-terminal pro-brain natriuretic peptide (NT-proBNP) in the \u2018between-group\u2019 analysis. Nevertheless, patients treated with high-dose furosemide + HSS showed significantly higher absolute delta values of IL-6 (2.3 \u00b1 1.2 vs. 1.7 \u00b1 0.9, P &amp;lt; 0.0005, and 2.0 \u00b1 0.8 vs. 1.85 \u00b1 1.1, P = 0.034), sST2 (41.2 \u00b1 8.6 vs. 27.9 \u00b1 7.6, P &amp;lt; 0.0005, and 37.1 \u00b1 6.6 vs. 28.4 \u00b1 6.7, P &amp;lt; 0.0005), high-sensitivity troponin T (0.03 \u00b1 0.02 vs. 0.02 \u00b1 0.01, P = 0.001, and 0.03 \u00b1 0.02 vs. 0.02 \u00b1 0.01, P = 0.009), NT-proBNP (7237 \u00b1 7931 vs. 3244 \u00b1 4159, P &amp;lt; 0.005, and 5381 \u00b1 4829 vs. 4466 \u00b1 4332, P = 0.004), and galectin-3 (15.7 \u00b1 3.2 ng\/mL vs. 11.68 \u00b1 1.9 ng\/mL, P &amp;lt; 0.0005, and 16.7 \u00b1 3.9 ng\/mL vs. 11.8 \u00b1 2.4 ng\/mL, P &amp;lt; 0.0005) than patients treated with furosemide alone. After acute saline load, patients treated with i.v. furosemide + HSS in comparison with subjects treated with furosemide alone showed a significantly lower increase in the serum concentrations of IL-6 (\u22120.26 \u00b1 0.42 pg\/mL vs. \u22121.43 \u00b1 0.86 pg\/mL, P &amp;lt; 0.0005), high-sensitivity troponin T (0 vs. \u22120.02 \u00b1 0.02 ng\/mL, P &amp;lt; 0.0005), sST2 (\u22128.5 \u00b1 5.9 ng\/mL vs. \u221214.6 \u00b1 6.2 ng\/mL, P &amp;lt; 0.0005), galectin-3 (\u22122.1 \u00b1 1.5 ng\/mL vs. \u22127.1 \u00b1 3.6 ng\/mL, P &amp;lt; 0.0005), and NT-proBNP (77 \u00b1 1373 vs. \u22121706 \u00b1 2259 pg\/mL, P &amp;lt; 0.0005).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings concerning a comparable degree of reduction in the serum levels of three cardinal biomarkers indicate that a reduction in serum heart failure markers is not linked to the higher degree of congestion relief with a more rapid achievement of a clinical compensation state. This issue may have possible benefits on clinical practice concerning its therapeutic effects over and beyond the simple amelioration of clinical congestion signs and symptoms. Nevertheless, our findings of higher delta values after treatment with i.v. furosemide plus HSS indicate a possible higher efficacy by means of modulation of the stretching and fibrosis mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13511","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T21:39:55Z","timestamp":1626817195000},"page":"4174-4186","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of Intravenous Furosemide Plus Small-Volume Hypertonic Saline Solutions on Markers of Heart Failure"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6440-7318","authenticated-orcid":false,"given":"Antonino","family":"Tuttolomondo","sequence":"first","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Maida","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Casuccio","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Di Raimondo","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Fonte","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Vassallo","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Puleo","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Di Chiara","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Mogavero","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Del Cuore","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Daidone","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Ortello","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pinto","sequence":"additional","affiliation":[{"name":"U.O. C di Medicina Interna con Stroke Care, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza \u201cG. D'Alessandro\u201d (PROMISE), University of Palermo , Piazza delle Cliniche n.2, Palermo, 90127 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"2026012114220608100_ehf213511-bib-0001","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jchf.2019.11.001","article-title":"Race and sex differences in modifiable risk factors and incident heart failure","volume":"8","author":"Kubicki","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2026012114220608100_ehf213511-bib-0002","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijcard.2019.12.050","article-title":"The history of the evolution of the knowledge about the diagnosis and the pathogenetic aspects of heart failure: from the Egyptians to James Mackenzie","volume":"304","author":"Bestetti","year":"2020","journal-title":"Int J Cardiol"},{"key":"2026012114220608100_ehf213511-bib-0003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2014.09.006","article-title":"Markers of fibrosis, inflammation, and remodeling pathways in heart failure","volume":"443","author":"Passino","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2026012114220608100_ehf213511-bib-0004","doi-asserted-by":"crossref","first-page":"M5","DOI":"10.1093\/eurheartj\/suz215","article-title":"Monitoring of biomarkers in heart failure","volume":"21","author":"Spoletini","year":"2019","journal-title":"Eur Heart J Suppl"},{"key":"2026012114220608100_ehf213511-bib-0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1586\/14779072.2013.832476","article-title":"Novel biomarkers for heart failure","volume":"11","author":"Iqbal","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026012114220608100_ehf213511-bib-0006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2459\/JCM.0000000000000741","article-title":"Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome","volume":"20","author":"Ruocco","year":"2019","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2026012114220608100_ehf213511-bib-0007","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.118.11157","article-title":"IL-33 (interleukin 33)\/sST2 axis in hypertension and heart failure","volume":"72","author":"Ghali","year":"2018","journal-title":"Hypertension"},{"key":"2026012114220608100_ehf213511-bib-0008","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.1038\/s41598-018-26115-y","article-title":"Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure","volume":"8","author":"Nguyen","year":"2018","journal-title":"Sci Rep"},{"key":"2026012114220608100_ehf213511-bib-0009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2015.03.033","article-title":"Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases","volume":"445","author":"Mueller","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2026012114220608100_ehf213511-bib-0010","doi-asserted-by":"crossref","first-page":"17007","DOI":"10.1038\/srep17007","article-title":"Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep"},{"key":"2026012114220608100_ehf213511-bib-0011","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/clc.23105","article-title":"Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis","volume":"42","author":"Anyfanti","year":"2019","journal-title":"Clin Cardiol"},{"key":"2026012114220608100_ehf213511-bib-0012","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/ejhf.1701","article-title":"Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T","volume":"22","author":"Aimo","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026012114220608100_ehf213511-bib-0013","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.amjcard.2007.11.070","article-title":"Usefulness of N-terminal pro-B-type natriuretic peptide increase with exercise for predicting cardiovascular mortality in patients with heart failure","volume":"101","author":"Ko\u00e7","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026012114220608100_ehf213511-bib-0014","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006541","article-title":"Comparison of BNP and NT-proBNP in patients with heart failure and reduced ejection fraction","volume":"13","author":"R\u00f8rth","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026012114220608100_ehf213511-bib-0015","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ Res"},{"key":"2026012114220608100_ehf213511-bib-0016","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10741-016-9533-z","article-title":"The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure","volume":"21","author":"Briasoulis","year":"2016","journal-title":"Heart Fail Rev"},{"key":"2026012114220608100_ehf213511-bib-0017","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ejhf.942","article-title":"Immune mechanisms in heart failure","volume":"19","author":"Zhang","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114220608100_ehf213511-bib-0018","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2026012114220608100_ehf213511-bib-0019","first-page":"219","article-title":"Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure","volume":"16","author":"Paterna","year":"1999","journal-title":"Adv Ther"},{"key":"2026012114220608100_ehf213511-bib-0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1388-9842(00)00094-5","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure","volume":"2","author":"Paterna","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"2026012114220608100_ehf213511-bib-0021","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhj.2003.166","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects","volume":"145","author":"Licata","year":"2003","journal-title":"Am Heart J"},{"key":"2026012114220608100_ehf213511-bib-0022","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.numecd.2009.10.014","article-title":"Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading","volume":"21","author":"Tuttolomondo","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2026012114220608100_ehf213511-bib-0023","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/hrt.2004.037762","article-title":"Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure","volume":"91","author":"Mueller","year":"2005","journal-title":"Heart"},{"key":"2026012114220608100_ehf213511-bib-0024","first-page":"741","article-title":"Guidelines for the diagnosis of heart failure","volume":"16","author":"Task force Heart Failure","year":"1995","journal-title":"Task Force Heart Fail Euro Soc Cardiol Eur Heart J"},{"key":"2026012114220608100_ehf213511-bib-0025","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2005.01.059","article-title":"Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study","volume":"45","author":"Paterna","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026012114220608100_ehf213511-bib-0026","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00380-017-0945-z","article-title":"Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis","volume":"32","author":"Fukui","year":"2017","journal-title":"Heart Vessels"},{"key":"2026012114220608100_ehf213511-bib-0027","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N Engl J Med"},{"key":"2026012114220608100_ehf213511-bib-0028","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","article-title":"Tumor necrosis factor-\u03b1 and tumor necrosis factor receptors in the failing human heart","volume":"93","author":"Torre-Amione","year":"1996","journal-title":"Circulation"},{"key":"2026012114220608100_ehf213511-bib-0029","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/hrt.72.6.561","article-title":"Increased circulating cytokines in patients with myocarditis and cardiomyopathy","volume":"72","author":"Matsumori","year":"1994","journal-title":"Br Heart J"},{"key":"2026012114220608100_ehf213511-bib-0030","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0735-1097(00)00912-8","article-title":"High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure","volume":"36","author":"Maeda","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026012114220608100_ehf213511-bib-0031","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: past, present, and the foreseeable future","volume":"29","author":"Mann","year":"2002","journal-title":"Circ Res"},{"key":"2026012114220608100_ehf213511-bib-0032","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/j.amjcard.2015.01.034","article-title":"The biology of ST2: the international ST2 consensus panel","volume":"115","author":"Pascual-Figal","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026012114220608100_ehf213511-bib-0033","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-5793(89)81679-5","article-title":"A putative protein of a growth specific cDNA from BALB\/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor","volume":"258","author":"Minaga","year":"1989","journal-title":"FEBS Lett"},{"key":"2026012114220608100_ehf213511-bib-0034","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"key":"2026012114220608100_ehf213511-bib-0035","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.jacc.2017.09.026","article-title":"Prognostic value of serial ST2 measurements in patients with acute heart failure","volume":"70","author":"van Vark","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012114220608100_ehf213511-bib-0036","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00392-015-0896-2","article-title":"A combined clinical and biomarker approach to predict diuretic response in acute heart failure","volume":"105","author":"ter Maaten","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"2026012114220608100_ehf213511-bib-0037","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.872","article-title":"Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"19","author":"Harjola","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114220608100_ehf213511-bib-0038","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Am J Physiol Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Cell Physiol"},{"key":"2026012114220608100_ehf213511-bib-0039","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s12325-015-0254-9","article-title":"Hypertonic saline in conjunction with high-dose furosemide improves dose\u2013response curves in worsening refractory congestive heart failure","volume":"32","author":"Paterna","year":"2015","journal-title":"Adv Ther"},{"key":"2026012114220608100_ehf213511-bib-0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00059-013-4041-6","article-title":"Hypertonic saline plus iv furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure","volume":"40","author":"De Vecchis","year":"2015","journal-title":"Herz"},{"key":"2026012114220608100_ehf213511-bib-0041","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0002-9610(89)90654-5","article-title":"Hypertonic salinedextran solutions for the prehospital management of traumatic hypotension","volume":"157","author":"Maningas","year":"1989","journal-title":"Am J Surg"},{"key":"2026012114220608100_ehf213511-bib-0042","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00134-008-1206-5","article-title":"Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery","volume":"35","author":"Redfors","year":"2009","journal-title":"Intensive Care Med"},{"key":"2026012114220608100_ehf213511-bib-0043","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-62-5-1003","article-title":"Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans","volume":"62","author":"Kimura","year":"1986","journal-title":"J Clin Endocrinol Metabol"},{"key":"2026012114220608100_ehf213511-bib-0044","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1189\/jlb.70.2.261","article-title":"Effects of hypertonic saline on expression of human polymorphonuclear leukocyte adhesion molecules","volume":"70","author":"Thiel","year":"2001","journal-title":"J Leukoc Biol"},{"key":"2026012114220608100_ehf213511-bib-0045","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai","year":"2009","journal-title":"Pharmacol Ther"},{"key":"2026012114220608100_ehf213511-bib-0046","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.repc.2014.03.006","article-title":"A Revisiting the slow force response: the role of the PKG signaling pathway in the normal and the ischemic heart","volume":"33","author":"Castro-Ferreira","year":"2014","journal-title":"Rev Port Cardiol"},{"key":"2026012114220608100_ehf213511-bib-0047","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00421-017-3783-x","article-title":"Traditional and new candidate cardiac biomarkers assessed before, early, and late after half marathon in trained subjects","volume":"118","author":"Vasalle","year":"2018","journal-title":"Eur J Appl Physiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13511","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13511","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/5\/4174\/65566012\/eschf_8_5_4174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/5\/4174\/65566012\/eschf_8_5_4174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:27:24Z","timestamp":1769023644000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/8\/5\/4174\/8345812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,7,20]]},"published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13511","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10]]},"published":{"date-parts":[[2021,7,20]]},"assertion":[{"value":"2021-03-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}